ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,292Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 939

$1.24M Total Retail Price of All Prescriptions

Rank: 23 out of 939

703 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 703 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 703 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 18,907 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 1,011 817 1 4
FUROSEMIDE 854 692 2 7
AMLODIPINE BESYLATE 843 733 3 6
SIMVASTATIN 748 553 4 2
METOPROLOL TARTRATE 711 463 5 10
LISINOPRIL 688 523 6 3
POTASSIUM CHLORIDE 663 528 7 9
METFORMIN HCL 587 464 8 8
OMEPRAZOLE 562 424 9 5
MELOXICAM 543 427 10 14
GABAPENTIN 536 340 11 11
HYDROCODONE-ACETAMINOPHEN 520 313 S3 12 1
TRAMADOL HCL 347 266 13 16
METOPROLOL SUCCINATE 332 319 14 21
HYDROCHLOROTHIAZIDE 322 250 15 12
CITALOPRAM HBR 308 234 16 15
ATENOLOL 303 259 17 19
ISOSORBIDE MONONITRATE ER 295 266 18 53
WARFARIN SODIUM 286 253 19 17
NEXIUM 277 168 20 18
RAMIPRIL 245 209 21 91
TRIAMTERENE-HCTZ 242 177 22 33
ZOLPIDEM TARTRATE 238 158 23 20
ATORVASTATIN CALCIUM 228 176 24 22
CYCLOBENZAPRINE HCL 219 96 R 25 36
FLUTICASONE PROPIONATE 211 156 26 43
NAPROXEN SODIUM 208 112 27 275
KLOR-CON M20 200 148 28 90
MIRTAZAPINE 196 179 29 56
AZITHROMYCIN 195 131 30 32
CLOPIDOGREL 193 165 31 28
TAMSULOSIN HCL 182 170 32 27
GLIMEPIRIDE 177 118 33 37
ALLOPURINOL 169 124 34 31
SPIRIVA 168 120 35 73
DIOVAN HCT 166 140 36 74
LOSARTAN-HYDROCHLOROTHIAZIDE 156 118 37 55
AMITRIPTYLINE HCL 153 78 R 38 38
CYMBALTA 153 111 38 44
DIGOXIN 149 136 40 45
FENOFIBRATE 148 80 41 83
RANITIDINE HCL 147 98 42 35
PLAVIX 144 119 43 48
ESTRADIOL 141 69 R 44 79
TRAZODONE HCL 140 83 45 26
PROAIR HFA 140 71 45 41
DOXYCYCLINE HYCLATE 129 95 47 84
DONEPEZIL HCL 129 123 47 30
CLONIDINE HCL 125 65 49 39
LANSOPRAZOLE 124 109 50 177
PRAVASTATIN SODIUM 124 104 50 13
VERAPAMIL ER 122 100 52 85
GLYBURIDE-METFORMIN HCL 118 58 R 53 98
LOSARTAN POTASSIUM 115 98 54 29
SYNTHROID 115 98 54 75
ROPINIROLE HCL 112 81 56 78
POLYETHYLENE GLYCOL 3350 111 87 57 57
AMLODIPINE BESYLATE-BENAZEPRIL 110 99 58 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 94 58 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 75 60 64
TIZANIDINE HCL 106 57 60 81
EXELON 106 106 60 151
SUCRALFATE 103 71 63 96
ADVAIR DISKUS 101 91 64 60
DIOVAN 101 85 64 50
FAMOTIDINE 99 71 66 62
SERTRALINE HCL 98 75 67 24
BENAZEPRIL HCL 98 85 67 87
DILTIAZEM ER 96 94 69 94
SPIRONOLACTONE 96 35 69 71
DILTIAZEM 24HR CD 92 75 71 126
LANTUS 91 51 72 59
TERAZOSIN HCL 91 70 72 114
PANTOPRAZOLE SODIUM 90 71 74 66
NAMENDA 89 89 75 49
CRESTOR 89 86 75 34
IBUPROFEN 89 38 75 112
INSULIN SYRINGE 87 45 78 97
METOCLOPRAMIDE HCL 86 46 79 119
PRAMIPEXOLE DIHYDROCHLORIDE 80 76 80 162
ESCITALOPRAM OXALATE 79 62 81 61
AMOXICILLIN 77 55 82 92
LEVEMIR FLEXPEN 76 36 83 190
PREDNISONE 75 52 84 42
LEVEMIR 75 60 84 168
GEMFIBROZIL 73 66 86 100
METOLAZONE 71 55 87 181
SYMBICORT 68 43 88 137
METHOCARBAMOL 68 54 R 88 149
CARVEDILOL 67 59 90 25
COMBIVENT 67 54 90 120
CIPROFLOXACIN HCL 66 59 92 54
KLOR-CON M10 66 63 92 163
PHENYTOIN SODIUM EXTENDED 65 44 94 99
LYRICA 65 35 94 63
QUETIAPINE FUMARATE 63 47 96 69
SINGULAIR 60 59 97 101
LEVOFLOXACIN 59 43 98 86
HYDRALAZINE HCL 58 45 99 130
LIPITOR 57 35 100 127
ENALAPRIL MALEATE 57 52 100 65
PROMETHAZINE HCL 56 33 R 102 68
DETROL LA 55 48 103 155
METRONIDAZOLE 54 38 104 238
CARBIDOPA-LEVODOPA 53 34 105 102
AGGRENOX 52 43 106 153
BACLOFEN 52 22 106 157
NIFEDIPINE ER 51 14 108 105
INDOMETHACIN 51 42 R 108 239
LOVAZA 51 29 108 191
QUINAPRIL HCL 50 43 111 133
PREMARIN 50 30 R 111 111
GLYBURIDE 50 37 R 111 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.